guest ::
| Home > Documents in Process > Quality over quantity - rethinking social participation in dementia prevention: results from the AgeWell.de trial > print |
| Home > Documents in Process > Quality over quantity - rethinking social participation in dementia prevention: results from the AgeWell.de trial > print |
| 001 | 282303 | ||
| 005 | 20251117142552.0 | ||
| 024 | 7 | _ | |a 10.1007/s00127-024-02757-4 |2 doi |
| 024 | 7 | _ | |a 0037-7813 |2 ISSN |
| 024 | 7 | _ | |a 0933-7954 |2 ISSN |
| 024 | 7 | _ | |a 1433-9285 |2 ISSN |
| 037 | _ | _ | |a DZNE-2025-01273 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Kosilek, Robert P. |0 0000-0003-3435-2242 |b 0 |
| 245 | _ | _ | |a Quality over quantity - rethinking social participation in dementia prevention: results from the AgeWell.de trial |
| 260 | _ | _ | |a Darmstadt |c 2024 |b Steinkopff |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1763385800_17169 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Social participation as a protective factor against cognitive decline was one of the targets in the AgeWell.de study, a multi-domain interventional trial in a sample of older adults at increased risk for dementia. This study aimed to examine differential effects of the intervention and other influencing factors on social participation throughout the trial.A longitudinal analysis of study data at the primary follow-up after 24 months (n = 819) was conducted. The Lubben Social Network Scale (LSNS-6) was used to assess quantitative aspects of social networks, and self-reported social activities were classified using a three-tiered categorical framework to capture qualitative aspects.A positive effect of the intervention was observed at the qualitative framework level, with an OR of 1.38 [95% CI: 1.05-1.82] for achieving or maintaining higher social participation at follow-up, while no effect could be detected on quantitative social network characteristics. Later phases of the Covid-19 pandemic showed a negative impact on the level of social participation at follow-up with an OR of 0.84 [95% CI: 0.75-0.95].These findings suggest that by focusing on qualitative aspects of social participation as a component of dementia prevention, future interventions can promote enriched social interactions within established social networks.German Clinical Trials Register (DRKS) ID DRKS00013555. |
| 536 | _ | _ | |a 353 - Clinical and Health Care Research (POF4-353) |0 G:(DE-HGF)POF4-353 |c POF4-353 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, Journals: pub.dzne.de |
| 650 | _ | 7 | |a Covid-19 |2 Other |
| 650 | _ | 7 | |a Dementia |2 Other |
| 650 | _ | 7 | |a Lifestyle intervention |2 Other |
| 650 | _ | 7 | |a Prevention |2 Other |
| 650 | _ | 7 | |a Randomized controlled trial |2 Other |
| 650 | _ | 7 | |a Social participation |2 Other |
| 700 | 1 | _ | |a Wendel, Flora |b 1 |
| 700 | 1 | _ | |a Zöllinger, Isabel |b 2 |
| 700 | 1 | _ | |a Knecht, Hanna Lea |0 P:(DE-2719)9002503 |b 3 |u dzne |
| 700 | 1 | _ | |a Blotenberg, Iris |0 P:(DE-2719)9001870 |b 4 |u dzne |
| 700 | 1 | _ | |a Weise, Solveig |b 5 |
| 700 | 1 | _ | |a Fankhänel, Thomas |b 6 |
| 700 | 1 | _ | |a Döhring, Juliane |b 7 |
| 700 | 1 | _ | |a Williamson, Martin |b 8 |
| 700 | 1 | _ | |a Luppa, Melanie |b 9 |
| 700 | 1 | _ | |a Zülke, Andrea E. |b 10 |
| 700 | 1 | _ | |a Brettschneider, Christian |b 11 |
| 700 | 1 | _ | |a Wiese, Birgitt |b 12 |
| 700 | 1 | _ | |a Hoffmann, Wolfgang |0 P:(DE-2719)2000040 |b 13 |u dzne |
| 700 | 1 | _ | |a Frese, Thomas |b 14 |
| 700 | 1 | _ | |a König, Hans-Helmut |b 15 |
| 700 | 1 | _ | |a Kaduszkiewicz, Hanna |b 16 |
| 700 | 1 | _ | |a Thyrian, Jochen René |0 P:(DE-2719)2290613 |b 17 |u dzne |
| 700 | 1 | _ | |a Riedel-Heller, Steffi G. |b 18 |
| 700 | 1 | _ | |a Gensichen, Jochen |b 19 |
| 773 | _ | _ | |a 10.1007/s00127-024-02757-4 |0 PERI:(DE-600)1463160-X |p - |t Social psychiatry and psychiatric epidemiology |v Advance online publication |y 2024 |x 0037-7813 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 3 |6 P:(DE-2719)9002503 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 4 |6 P:(DE-2719)9001870 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 13 |6 P:(DE-2719)2000040 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 17 |6 P:(DE-2719)2290613 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-353 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Clinical and Health Care Research |x 0 |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2024-12-20 |w ger |
| 915 | _ | _ | |a DEAL Springer |0 StatID:(DE-HGF)3002 |2 StatID |d 2024-12-20 |w ger |
| 915 | _ | _ | |a DEAL Springer |0 StatID:(DE-HGF)3002 |2 StatID |d 2024-12-20 |w ger |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2024-12-20 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2024-12-20 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2024-12-20 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2024-12-20 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1180 |2 StatID |b Current Contents - Social and Behavioral Sciences |d 2024-12-20 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0130 |2 StatID |b Social Sciences Citation Index |d 2024-12-20 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2024-12-20 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2024-12-20 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2024-12-20 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b SOC PSYCH PSYCH EPID : 2022 |d 2024-12-20 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2024-12-20 |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2024-12-20 |
| 915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |d 2024-12-20 |
| 920 | 1 | _ | |0 I:(DE-2719)1510900 |k AG Rodriguez |l Psychosocial Epidemiology and Public Health |x 0 |
| 920 | 1 | _ | |0 I:(DE-2719)1510800 |k AG Thyrian |l Interventional Health Care Research (IHCR) |x 1 |
| 920 | 1 | _ | |0 I:(DE-2719)1510600 |k AG Hoffmann |l Translational Health Care Research |x 2 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a EDITORS |
| 980 | _ | _ | |a VDBINPRINT |
| 980 | _ | _ | |a I:(DE-2719)1510900 |
| 980 | _ | _ | |a I:(DE-2719)1510800 |
| 980 | _ | _ | |a I:(DE-2719)1510600 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|